Procode AI

About Procode AI

Procode AI is a technology company specializing in AI-powered revenue cycle management (RCM) for surgeons in private practice. Founded in 2024 by Jeff Cripe, Kameron Rezzadeh, M.D., and James Baez-Silva, the company aims to modernize and automate the complex process of medical billing for surgical procedures. It launched from stealth in early 2026 with $4 million in funding and the strategic acquisition of The Auctus Group, a prominent US biller for plastic surgeons and dermatologists.

The company's core offering is an AI-powered platform designed to automate coding, streamline claims management, and improve reimbursement outcomes for medical practices. The flagship product, the "Coding Copilot," leverages artificial intelligence to translate operative reports into the correct billing and diagnostic codes (CPT, Dx, Modifiers). This tool integrates directly with Electronic Health Record (EHR) systems to pull patient records, code them while cross-checking against billing rules (NCCI/MUE/LCD), and prepare charges for human review before submission. Procode AI states its solution enables medical coders to work up to 90% faster, increases accuracy, reduces coding-related denials, and decreases accounts receivable (AR) days.

Procode's business model is centered on providing its intelligent billing infrastructure to a market that has historically been underserved by advanced AI technology, which was often reserved for large healthcare systems. The company serves specialties such as Plastic Surgery, Dermatology, ENT, Urology, Ophthalmology, and various surgical fields. By acquiring The Auctus Group, founded in 2012, Procode immediately expanded its reach to over 300 providers and demonstrated significant financial impact, adding $2 million in annual recurring revenue within five months post-acquisition.

The founding team combines expertise in technology and medicine. This background informs their focus on building technology that ensures providers are reimbursed fairly and quickly, allowing them to concentrate on patient care rather than administrative burdens. The company has received backing from investors including Story Ventures, CHAP Health Ventures, and Progression Fund.